Chung Kevin purchased $7K of ICU
Chung Kevin (Chief Medical Officer) purchased 7,800 shares of SeaStar Medical Holding Corp (ICU) at $0.84 on 2026-11-16.
How this was made
The 30-second read
Why it matters
This provides incremental sentiment information (insider buying) but no operational or financial update that would typically reset valuation expectations.
Market read
Traders may note the insider purchase, but the disclosure alone is unlikely to be a standalone catalyst.
What to watch
The filing does not state the insider’s rationale, and the absence of a 10b5-1 plan does not by itself confirm conviction or timing advantage.
Background
The article is an SEC Form 4 insider transaction disclosure for SeaStar Medical Holding Corp.
Ticker impact
SeaStar Medical Holding CMO Kevin Chung bought 7,800 shares at $0.8448 on 2026-11-16, per a fresh SEC Form 4 filing.
Likely limited near-term impact, with any effect confined to sentiment around insider activity.
The disclosure is a primary Form 4, but the transaction size is small and there is no accompanying guidance, deal, or operational catalyst in the text.
Market effects
Minimal, as this is company-specific insider activity with no sector-wide signal in the provided text.
None indicated.
None indicated.
Counterpoint
Insider buys can reflect diversification or routine liquidity needs rather than a strong forward-looking signal, especially without a 10b5-1 plan context.
Key entities
- issuerSeaStar Medical Holding Corp
US-listed company (ICU) whose CMO filed an insider purchase on Form 4.
- insiderKevin Chung
Chief Medical Officer who purchased shares in an open-market transaction.
